Prospects for immunotoxin therapy in cancer.

A. E. Frankel, L. L. Houston, B. F. Issell, G. Fathman

Research output: Contribution to journalReview article

51 Scopus citations

Abstract

Immunotoxins are formed by chemically linking antibodies to "toxic" polypeptides that inactivate protein synthesis. These hybrid protein molecules are guided to tumor cells by the antibody moiety, and once bound to the tumor cells, the toxic polypeptide moiety penetrates the cell membrane and enzymatically inactivates protein synthesis. A stepwise approach to identifying the potential clinical uses of immunotoxins in cancer therapy is examined in this chapter.

Original languageEnglish (US)
Pages (from-to)125-142
Number of pages18
JournalAnnual review of medicine
Volume37
DOIs
StatePublished - 1986

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Prospects for immunotoxin therapy in cancer.'. Together they form a unique fingerprint.

  • Cite this